Prof.  Malfertheiner, Prof. Leja, Dr. Schulz and RICHEN to Speak at AHMSG 2024 in SA

From August 16-17 2024, Cape Town, South Africa, Profs. Malfertheiner, Leja, Dr. Schulz, Richen Hongkong Sight and other speakers are billed to speak at the first ever International Conference of the African Helicobacter & Microbiota Study Group (AHMSG).

The two-day International Conference which is free for students and Resident doctors will hold at the President Hotel, Alexander Road, Bantry Bay, Cape Town, South Africa.

Peter Malfertheiner who is the keynote speaker at the conference, is a Professor of Medicine and Chairman of Department of Gastroenterology, Hepatology and Infectious disease at Otto v. Guericke University of Magdeburg in Germany since 1995.

He is the founding member of the European Helicobacter & Microbiota Study Group (EHMSG).

Prof. Malfertheiner’s, primary research interests include Helicobacter pylori– associated clinical manifestations, gastric cancer and pancreatic diseases.

Prof. Leja is a Professor of Medicine and Vice-dean, Faculty of Medicine, University of Latvia. He is a Gastroenterologist, Digestive Diseases Centre GASTRO. His research interests are Helicobacter pylori, gastritis and gastric cancer, prevention of gastrointestinal cancer, celiac disease, diagnostic methods in gastroenterology and oncology

Dr. Schulz was Director of Medical Department 2, LMU-Hospital Munich, Germany. His research interests revolve around, Helicobacter pylori, Gastrointestinal microbiome beyond Helicobacter pylori, gastrointestinal microbiome & gastrointestinal diseases including IBS, Gastrointestinal microbiome & autonomy in the elderly. Effect of microbial community on health & diseases and Helicobacter cancer.

Richen as the present company of Richen Sight Hong Kong was founded in July 2002 with the history of more than 10 years. Richen over the years has developed its outstanding enterprise culture as Honesty, Innovation, Rapidity, Learn, Honour Harmony, Competition and Customer to contribute to its success in business, inspiring every Richener to help to win the high reputation in markets. In the bid to guarantee the sustainable improvement in services and quality, Richen has established the system management according to ISO 9001 and ISO 13485, authenticated by China Medical Device CMD in China and Technical Inspection Association (TUV) in Germany.

In addition, a number of the Richen products have been regulated and they possess the Conformite European (CE) safety certificate.

The African Helicobacter and Microbiota Study Group (AHMSG), founded in 2022, aimed at establishing appropriate diagnostic methods and guidelines for the treatment and management of Helicobacter pylori (an ulcer causing pathogen) infections in Africa similar to the Maastricht VI Florence Consensus Report of the European Helicobacter & Microbiota Study Group and to connect with EHMSG for advice as a parent body.

Professor Stella Smith FAS is the founding President of the AHMSG since 2022, bringing in 16 members from ten African countries as Board members from Nigeria, South Africa, Zambia, Kenya, Cameroon, Tanzania, Democratic Republic of Congo, Namibia, Senegal and Morocco. The group also comprises over 90 ordinary members. The Group has been involved in formulating recommendations for the appropriate diagnosis and treatment of H. pylori (an ulcer causing pathogen). Prof. Smith FAS will be handing over to Prof. Mashiko from South Africa who will pilot the affairs of the AHMSG for the next two years.